ACTH, calcitonin and ADH as tumour markers in lung cancer

1984 ◽  
Vol 104 (4_Supplb) ◽  
pp. S57
Author(s):  
W. WINKELMANN ◽  
U. DEUSS ◽  
W. HUMMERICH ◽  
D. KAULEN ◽  
H. BROSCH ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tumour Markers

scholarly journals Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results?

1995 ◽  
Vol 72 (1) ◽  
pp. 170-173 ◽  
Author(s):  
M Plebani ◽  
D Basso ◽  
F Navaglia ◽  
M De Paoli ◽  
A Tommasini ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Evaluation ◽  
Cancer Diagnosis ◽  
Tumour Markers ◽  
Lung Cancer Diagnosis

Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays

2004 ◽  
Vol 203 (1) ◽  
pp. 584-593 ◽  
Author(s):  
Harriet Wikman ◽  
Jouni K Seppänen ◽  
Virinder K Sarhadi ◽  
Eeva Kettunen ◽  
Kaisa Salmenkivi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tissue Microarrays ◽  
Tumour Markers ◽  
Combined Use

Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers

Respirology ◽  
2014 ◽  
Vol 19 (5) ◽  
pp. 707-713 ◽  
Author(s):  
Huaping Dai ◽  
Jianqun Liu ◽  
Lirong Liang ◽  
Chengjun Ban ◽  
Jing Jiang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Interstitial Lung Disease ◽  
Cancer Risk ◽  
Lung Disease ◽  
Lung Cancer Risk ◽  
Tumour Markers ◽  
Serum Tumour

Tumour markers in bronchial lavage in lung cancer

1993 ◽  
Vol 29 ◽  
pp. S245
Author(s):  
J. Zaleska ◽  
M. Pirozynski ◽  
S. Kwiek ◽  
E. Rowinska-Zakrzewska
Keyword(s):  
Lung Cancer ◽  
Tumour Markers ◽  
Bronchial Lavage

Tumour markers and oncogenes in lung cancer

1991 ◽  
Vol 27 (10) ◽  
pp. 1323-1327 ◽  
Author(s):  
Tomi P Mäkelä ◽  
Karin Mattson ◽  
Kari Alitalo
Keyword(s):  
Lung Cancer ◽  
Tumour Markers

Pre-operative serum levels of angiogenic tumour markers in non-small cell lung cancer and its impact on survival

1999 ◽  
Vol 35 ◽  
pp. S250
Author(s):  
D. Brattström ◽  
M. Bergqvist ◽  
P. Hesselius ◽  
A. Larsson ◽  
K. Lamberg ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Serum Levels ◽  
Small Cell ◽  
Tumour Markers ◽  
Small Cell Lung ◽  
Impact On Survival

scholarly journals Diagnostic Role of Tumour Markers CEA, CA15-3, CA19-9 and CA125 in Lung Cancer

2012 ◽  
Vol 28 (1) ◽  
pp. 24-29 ◽  
Author(s):  
Indranath Ghosh ◽  
Debojyoti Bhattacharjee ◽  
Anjan Kumar Das ◽  
Goutam Chakrabarti ◽  
Anindya Dasgupta ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tumour Markers ◽  
Diagnostic Role

The significance of tumour markers as an indication for mediastinoscopy in non-small cell lung cancer

Respirology ◽  
2003 ◽  
Vol 8 (2) ◽  
pp. 163-167 ◽  
Author(s):  
Soichiro ANDO ◽  
Hideki KIMURA ◽  
Naomichi IWAI ◽  
Kimitaka KAKIZAWA ◽  
Masayuki SHIMA ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Tumour Markers ◽  
Small Cell Lung

Neuron-Specific Enolase in the Diagnosis and Therapy Monitoring of Lung Cancer: A Comparison with Cea, Tpa, Ferritin and Calcitonin

1986 ◽  
Vol 1 (3) ◽  
pp. 129-136 ◽  
Author(s):  
Wolfgang Fischbach ◽  
Berthold Jany
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Therapy Monitoring ◽  
Neuron Specific Enolase ◽  
Tumour Marker ◽  
Small Cell ◽  
Tumour Markers ◽  
Small Cell Lung

The significance of neuron-specific enolase (NSE) in the diagnosis and treatment monitoring of lung cancer was investigated in comparison with such established tumour markers as carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), ferritin and calcitonin. We determined the serum concentrations of these tumour markers in 25 patients with small cell lung cancer (SCLC), 30 patients with non small cell lung cancer (NSCLC), and 38 patients with benign pulmonary diseases (BPD). In 14 patients with lung cancer, it was possible to follow up the behaviour of the tumour markers under treatment for up to 16 months. Calcitonin proved to have a surprisingly low sensitivity for SCLC. The utility of TPA and of ferritin was restricted, although the sensitivity was comparably high, by the high rate of false positive results. For NSCLC, CEA proved to be the best tumour marker. At present, NSE appears to be the tumour marker with the greatest specificity and sensitivity for SCLC. Its determination in the diagnosis, treatment and follow-up of SCLC makes good sense.

Sign in / Sign up

Export Citation Format

Share Document